These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20008710)

  • 1. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials.
    Bhavsar AR; Googe JM; Stockdale CR; Bressler NM; Brucker AJ; Elman MJ; Glassman AR;
    Arch Ophthalmol; 2009 Dec; 127(12):1581-3. PubMed ID: 20008710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The article by Fintak et al on the incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab.
    El-Ashry MF; Dhillon B
    Retina; 2009 May; 29(5):720-1; author reply 721-2. PubMed ID: 19430287
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab.
    Fintak DR; Shah GK; Blinder KJ; Regillo CD; Pollack J; Heier JS; Hollands H; Sharma S
    Retina; 2008; 28(10):1395-9. PubMed ID: 18827737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections.
    Cheung CS; Wong AW; Lui A; Kertes PJ; Devenyi RG; Lam WC
    Ophthalmology; 2012 Aug; 119(8):1609-14. PubMed ID: 22480743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics.
    Bhavsar AR; Stockdale CR; Ferris FL; Brucker AJ; Bressler NM; Glassman AR;
    Arch Ophthalmol; 2012 Jun; 130(6):809-10. PubMed ID: 22801859
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute endophthalmitis after intravitreal injection and preventive effect of preoperative topical antibiotics.
    Park Y; Kim KS; Park YH
    J Ocul Pharmacol Ther; 2013 Dec; 29(10):900-5. PubMed ID: 24067061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.
    Bhatt SS; Stepien KE; Joshi K
    Retina; 2011 Nov; 31(10):2032-6. PubMed ID: 21659941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask.
    Shimada H; Hattori T; Mori R; Nakashizuka H; Fujita K; Yuzawa M
    Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):1885-90. PubMed ID: 23389553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT).
    Meredith TA; McCannel CA; Barr C; Doft BH; Peskin E; Maguire MG; Martin DF; Prenner JL;
    Ophthalmology; 2015 Apr; 122(4):817-21. PubMed ID: 25600198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endophthalmitis after intravitreal injection: the importance of viridans streptococci.
    Chen E; Lin MY; Cox J; Brown DM
    Retina; 2011 Sep; 31(8):1525-33. PubMed ID: 21878800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION: Role of Prophylactic Topical Ophthalmic Antibiotics.
    Li AL; Wykoff CC; Wang R; Chen E; Benz MS; Fish RH; Wong TP; Major JC; Brown DM; Schefler AC; Kim RY; OʼMalley RE
    Retina; 2016 Jul; 36(7):1349-56. PubMed ID: 26655622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Endophthalmitis after Intravitreal Injection: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine Strength.
    Stem MS; Rao P; Lee IJ; Woodward MA; Faia LJ; Wolfe JD; Capone A; Covert D; Dass AB; Drenser KA; Garretson BR; Hassan TS; Margherio A; Oh KT; Raephaelian PV; Randhawa S; Sneed S; Trese MT; Yedavally S; Williams GA; Ruby AJ
    Ophthalmol Retina; 2019 Jan; 3(1):3-7. PubMed ID: 30929813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor: Experience in Saudi Arabia.
    Al-Rashaed S; Alsulaiman SM; Alrushood AA; Almasaud J; Arevalo JF
    Middle East Afr J Ophthalmol; 2016; 23(1):60-3. PubMed ID: 26957840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.
    Inoue M; Kobayakawa S; Sotozono C; Komori H; Tanaka K; Suda Y; Matsushima H; Kinoshita S; Senoo T; Tochikubo T; Kadonosono K
    Ophthalmologica; 2011; 226(3):145-50. PubMed ID: 21811052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
    Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
    Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapy.
    Lima LH; Zweifel SA; Engelbert M; Sorenson JA; Slakter JS; Cooney MJ; Klancnik JM; Yannuzzi LA; Freund KB
    Retina; 2009 Oct; 29(9):1213-7. PubMed ID: 19934815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates.
    Englander M; Chen TC; Paschalis EI; Miller JW; Kim IK
    Br J Ophthalmol; 2013 Apr; 97(4):460-5. PubMed ID: 23390167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No increase in incidence of post-intravitreal injection endophthalmitis without topical antibiotics: a prospective study.
    Tanaka K; Shimada H; Mori R; Nakashizuka H; Hattori T; Okubo Y
    Jpn J Ophthalmol; 2019 Sep; 63(5):396-401. PubMed ID: 31446502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complications of intravitreal injections--own experience].
    Jamrozy-Witkowska A; Kowalska K; Jankowska-Lech I; Terelak-Borys B; Nowosielska A; Grabska-Liberek I
    Klin Oczna; 2011; 113(4-6):127-31. PubMed ID: 21913440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of endophthalmitis after intravitreal injection of antivascular endothelial growth factor medications using topical lidocaine gel anesthesia.
    Inman ZD; Anderson NG
    Retina; 2011 Apr; 31(4):669-72. PubMed ID: 21178659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.